Announcing Recipients of the Golden Ticket Program
Nitrome Biosciences and SyntheX are the recipients of the MBC 2018 Golden Ticket program sponsored by Celgene Corporation.
Peninsula Alzheimer’s fighter hunts $150 million IPO
Alector's Arnon Rosenthal (left) and Sabah Oney. TODD JOHNSON | SAN FRANCISCO BUSINESS TIMES By Ron Leuty – Reporter, San Francisco Business Times Jan 7, 2019, 5:18pm EST Read original online a [...]
Japanese Life Science Innovation
January 10, 2019 2:30 - 4:30pm Beyond Next Ventures and MBC BioLabs invite you to explore the latest in Japanese life science innovation on January 10th, when seven startups specially selected for t [...]
Prellis Biologics and CELLINK Sign Partnership
Prellis Biologics and CELLINK Sign Partnership Prellis Biologics and CELLINK sign partnership to commercialize high-resolution holographic bioprinting technology for micro-printing.The partners [...]
Mammoth Biosciences Featured on Forbes 30 Under 30
Mammoth Biosciences Featured on Forbes 30 Under 30 Congratulations to Trevor Martin, CEO of Mammoth Biosciences, who was featured on Forbes 2019 Healthcare 30 Under 30. Trevor is a 29-year-old S [...]
Celebration for ViewPoint Therapeutics
November 16, 2018 3:30 - 5pm After closing a $35 million Series B, ViewPoint Therapeutics will be moving to their own lab space in South San Francisco. They were one of the very first companies to m [...]
Open House in San Carlos
November 1st, 2018 3:30-6pm Come to meet MBC BioLabs residents, tour our new space in San Carlos, and hear about our exciting plans for the future. There will be posters from our companies, a live b [...]